BioLight Life Sciences Ltd. (TLV:BOLT)
Israel · Delayed Price · Currency is ILS · Price in ILA 265.00
+3.50 (1.34%)
Aug 24, 2026, 10:42 AM IDT
BioLight Life Sciences Market Cap
BioLight Life Sciences has a market cap or net worth of 23.74 million as of August 21, 2026. Its market cap has decreased by -4.35% in one year.
Market Cap
23.74M
Enterprise Value
6.78M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
265.00
ChartMarket Cap Chart
Since January 11, 2006, BioLight Life Sciences's market cap has decreased from 47.74M to 23.74M, a decrease of -50.27%. That is a compound annual growth rate of -3.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 23.74M | -25.41% |
| Dec 31, 2025 | 31.83M | 25.69% |
| Dec 31, 2024 | 25.32M | 4.99% |
| Dec 31, 2023 | 24.12M | -19.99% |
| Dec 29, 2022 | 30.15M | -42.70% |
| Dec 30, 2021 | 52.62M | 53.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 334.04M |
| Bonus BioGroup | 212.60M |
| Matricelf | 73.35M |
| BioLineRx | 41.94M |
| Clal Biotechnology Industries | 37.96M |
| Can-Fite BioPharma | 23.02M |
| XTL Biopharmaceuticals | 19.66M |
| Purple Biotech | 18.65M |